NEW YORK--(BUSINESS WIRE)-- 5th August 2025 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 4th August 2025 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker BNP Paribas Securities Corp. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price per shar
Related Questions
At what price were the shares redeemed relative to the volume-weighted average price and the daily high/low, and does that reflect a discount or premium?
What is the expected impact on earnings per share (EPS) and other per-share metrics after the shares are cancelled?
What is the rationale behind the timing of this buyback—does it coincide with any other corporate events or strategic initiatives?
What was the total dollar amount spent on the share buyback and how does it compare to CRH's recent cash flow and debt levels?
Will the redemption affect the voting rights distribution or any specific shareholder agreements?
Will this buyback be reflected in the next quarterly earnings release, and how will it affect reported net income and cash balances?
Does the buyback signal confidence from management about the company's future prospects, or is it primarily a financial engineering move?
How are the market participants (institutional investors, analysts) reacting to the buyback announcement in terms of price target revisions or analyst ratings?
How does CRH's share repurchase strategy compare with those of its main competitors in the building materials sector?
How does the size of this buyback (number of shares and percentage of outstanding shares) compare to previous buybacks by CRH?
What financing source was used for the share repurchase (e.g., cash on hand, debt issuance), and what does that imply about CRH's capital structure?
What impact could this buyback have on the stock's liquidity and trading volume in the short term?
Are there any potential risks, such as the company overpaying for shares or reducing financial flexibility?
Are there any regulatory or tax implications—especially with the transaction occurring via a U.S. broker—for non‑U.S. shareholders?
Is there a set timeline or limit to the overall share repurchase program, and will the company continue buying shares in the future?